Lic Mf Healthcare Fund Datagrid
Category Pharma Fund
BMSMONEY Rank N/A
Rating N/A
Growth Option 19-08-2026
NAV ₹33.72(R) -0.36% ₹37.34(D) -0.36%
Returns 1Y 3Y 5Y 7Y 10Y
Lumpsum Regular 13.71% 20.68% -% -% -%
Direct 15.22% 22.22% -% -% -%
Nifty Pharma TRI 19.97% 20.53% 14.18% 19.98% 9.31%
SIP (XIRR) Regular 26.43% 16.96% -% -% -%
Direct 28.08% 18.46% -% -% -%
Ratio Sharpe Ratio Sortino Ratio Sterling Ratio Jensen's Alpha Treynor Ratio
Risk STD. Dev VaR 1Y95% Max DD Beta Semi Devi.
Fund AUM As on: 30/12/2025 86 Cr
Top Pharma Fund
Fund Name Rank Rating
- -
- -
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund -
DSP Healthcare Fund -
Aditya Birla Sun Life Pharma & Healthcare Fund -
Mirae Asset Healthcare Fund -
Nippon India Pharma Fund -
Tata India Pharma & Healthcare Fund -

NAV Date: 19-08-2026

Scheme Name NAV Rupee Change Percent Change
LIC MF Healthcare Fund-Regular Plan-Growth 33.72
-0.1200
-0.3600%
LIC MF Healthcare Fund-Regular Plan-IDCW 33.73
-0.1200
-0.3600%
LIC MF Healthcare Fund-Direct Plan-IDCW 37.33
-0.1300
-0.3600%
LIC MF Healthcare Fund-Direct Plan-Growth 37.34
-0.1300
-0.3600%

Review Date: 19-08-2026

Investors beware: Mutual Fund investments are subject to market risks. Please read the scheme related documents carefully.

Data Source: www.amfiindia.com

SEBI Categorization


KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 2.65 1.28
2.10
-1.46 | 4.86 5 | 15 Good
3M Return % 7.98 6.18
8.60
2.76 | 12.49 9 | 15 Average
6M Return % 19.63 17.77
19.32
12.73 | 24.61 8 | 15 Good
1Y Return % 13.71 19.97
15.41
7.06 | 22.92 10 | 14 Average
3Y Return % 20.68 20.53
20.11
17.79 | 21.81 3 | 8 Good
1Y SIP Return % 26.43
26.04
-5.89 | 37.89 9 | 14 Average
3Y SIP Return % 16.96
14.49
4.97 | 18.11 3 | 8 Good
Return data last Updated On : Aug. 19, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Rotate the phone! Best viewed in landscape mode on mobile.
KPIs* Fund Nifty Pharma TRI Cat. Avg Min | Max Rank (In Cat.) Performance
1M Return % 2.76 1.28 2.21 -1.41 | 5.01 5 | 15 Good
3M Return % 8.34 6.18 8.97 2.96 | 12.97 9 | 15 Average
6M Return % 20.46 17.77 20.16 13.22 | 25.65 8 | 15 Good
1Y Return % 15.22 19.97 17.06 7.93 | 24.32 10 | 14 Average
3Y Return % 22.22 20.53 21.65 18.85 | 22.82 3 | 8 Good
1Y SIP Return % 28.08 27.80 -4.55 | 40.16 9 | 14 Average
3Y SIP Return % 18.46 15.97 6.48 | 19.83 3 | 8 Good
Return data last Updated On : Aug. 19, 2026.
Other parameters, fund ranking, non return related analysis are updated after every month end. Last Updated On : June 30, 2026
KPIs: Key Performance Indicators

Disclaimer: Past performance may or may not be sustained in future and should not be used as a basis for comparison with other investments. Returns for periods above 1 year are annualised.


Date Lic Mf Healthcare Fund NAV Regular Growth Lic Mf Healthcare Fund NAV Direct Growth
19-08-2026 33.7247 37.3375
18-08-2026 33.8472 37.4718
17-08-2026 33.7783 37.3942
14-08-2026 33.8526 37.4725
13-08-2026 33.9573 37.587
12-08-2026 33.9303 37.5558
11-08-2026 34.2008 37.8539
10-08-2026 33.8977 37.5171
07-08-2026 33.971 37.5942
06-08-2026 33.756 37.3549
05-08-2026 33.3785 36.9359
04-08-2026 33.2521 36.7947
03-08-2026 33.3341 36.8841
31-07-2026 33.1717 36.7004
30-07-2026 33.0724 36.5893
29-07-2026 33.2806 36.8183
28-07-2026 32.7384 36.2172
27-07-2026 32.7553 36.2346
24-07-2026 32.3129 35.7414
23-07-2026 32.4466 35.888
22-07-2026 32.6225 36.0813
21-07-2026 32.9174 36.4061
20-07-2026 32.8539 36.3346

Fund Launch Date: 28/Feb/2019
Fund Category: Pharma Fund
Investment Objective: The objective of the Scheme is to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors. There is no assurance that the investment objective of the Scheme will be achieved.
Fund Description: An open-ended equity scheme investing in Healthcare and Allied sectors
Fund Benchmark: BSE Healthcare- TRI
Source: Fund FactSheet

Disclaimer: NO INVESTMENT ADVICE. The Content is for informational purposes only.